[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100482460":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":15,"locations":24,"responsibleParty":68,"collaborators":70,"id":75,"slug":76,"hasResults":77,"nctId":78,"briefTitle":79,"officialTitle":79,"acronym":10,"eligibilityCriteria":80,"healthyVolunteers":77,"sex":81,"minAge":82,"maxAge":10,"enrollmentInfo":83,"targetDuration":10,"studyType":86,"phases":10,"briefSummary":87,"conditions":88,"keywords":90,"overallStatus":27,"whyStopped":10,"lastUpdateSubmitDate":94,"lastUpdatePostDateStruct":95,"startDateStruct":98,"completionDateStruct":100,"leadSponsor":102,"locationsCount":103},{"fullName":5,"class":6},"Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia","OTHER",[8,12],{"label":9,"type":10,"description":11,"interventionNames":10},"MKP vaccination for pre-exposure prophylaxis (HIV positive)",null,"HIV positive individuals who receive MKP vaccination for pre-exposure prophylaxis",{"label":13,"type":10,"description":14,"interventionNames":10},"MKP vaccination for pre-exposure prophylaxis (seronegative individuals)","HIV seronegative individuals who receive MKP vaccination for pre-exposure prophylaxis",[16,21],{"name":17,"role":18,"phone":19,"phoneExt":10,"email":20},"Beatriz Mothe, PhD, MD","CONTACT","676142408","bmothe@irsicaixa.es",{"name":22,"role":18,"phone":19,"phoneExt":10,"email":23},"Susana Benet, PhD, MD","sbenet@lluita.org",[25,46,58],{"facility":26,"status":27,"city":28,"state":29,"zip":30,"country":31,"countryCode":32,"cosmosGeoPoint":33,"geoPoint":38,"contacts":39},"Germans Trias i Pujol Hospital","RECRUITING","Badalona","Barcelona","08916","Spain","ES",{"type":34,"coordinates":35},"Point",[36,37],2.24741,41.45004,{"lat":37,"lon":36},[40,43],{"name":41,"role":42,"phone":10,"phoneExt":10,"email":10},"Bea Mothe, MD,PhD","PRINCIPAL_INVESTIGATOR",{"name":44,"role":45,"phone":10,"phoneExt":10,"email":10},"Susana Benet, MD,PhD","SUB_INVESTIGATOR",{"facility":47,"status":27,"city":29,"state":29,"zip":48,"country":31,"countryCode":32,"cosmosGeoPoint":49,"geoPoint":53,"contacts":54},"BCN Checkpoint","08015",{"type":34,"coordinates":50},[51,52],2.15899,41.38879,{"lat":52,"lon":51},[55],{"name":56,"role":18,"phone":10,"phoneExt":10,"email":57},"Ángel Rivero Calaf, MD,PhD","arivero@lluita.org",{"facility":59,"status":60,"city":29,"state":29,"zip":61,"country":31,"countryCode":32,"cosmosGeoPoint":62,"geoPoint":64,"contacts":65},"VALLE HEBRÓN HOSPITAL\u002FCentro Salud Internacional y Enfermedades Transmisibles Drassanes","NOT_YET_RECRUITING","08035",{"type":34,"coordinates":63},[51,52],{"lat":52,"lon":51},[66],{"name":67,"role":18,"phone":10,"phoneExt":10,"email":10},"Vicente Descalzo Jorro, MD,PhD",{"type":69,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[71,73],{"name":72,"class":6},"IrsiCaixa",{"name":47,"class":74},"INDUSTRY","100482460","characterization-of-vaccine-induced-responses-against-monkeypox-movihvax-an-observational-prospective-cohort-study-100482460",false,"NCT05562323","Characterization of Vaccine-induced Responses Against Monkeypox (MoVIHvax) An Observational Prospective Cohort Study","Inclusion Criteria:\n\n1. Adult individuals of ≥18 years old.\n2. Willing to comply with the requirements of the protocol and available for follow-up for the planned duration of the trial.\n3. Has understood the information provided and capable of giving informed consent.\n\nExclusion Criteria:\n\n1\\. Participant has any medical condition and\u002For finding that in the investigator opinion might increase participant risks, interfere with the study or impair interpretation of study data.","ALL","18 Years",{"count":84,"type":85},100,"ESTIMATED","OBSERVATIONAL","This observational study has been designed to characterize humoral and cellular immune responses after vaccination against monkeypox (MKP) in HIV positive and negative individuals at high risk of MKP infection during the vaccination campaign in the current monkeypox outbreak.",[89],"Monkeypox",[91,92,93],"Monkeypox vaccine","Immune responses","HIV","2026-06-29",{"date":96,"type":97},"2026-07-01","ACTUAL",{"date":99,"type":97},"2022-09-14",{"date":101,"type":85},"2026-08",{"name":5,"class":6},3]